Study Details

Back
Study ID 1585-CL-0101
Study Title Phase III study of ASP1585
A placebo controlled, phase III study in predialysis chronic kidney disease patients with hyperphosphatemia(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT01742585
Compound Name ASP1585 / bixalomer
Medical Indication or Disease Hyperphosphatemia
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 22-Oct-2012
Study Completion Date 16-May-2014
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS